298 related articles for article (PubMed ID: 14517509)
1. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
[TBL] [Abstract][Full Text] [Related]
2. Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.
Rosthøj S; Rajantie J; Treutiger I; Zeller B; Tedgård U; Henter JI;
Acta Paediatr; 2012 Jul; 101(7):761-6. PubMed ID: 22429281
[TBL] [Abstract][Full Text] [Related]
3. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
Neunert CE; Buchanan GR; Imbach P; Bolton-Maggs PH; Bennett CM; Neufeld EJ; Vesely SK; Adix L; Blanchette VS; Kühne T;
Blood; 2008 Nov; 112(10):4003-8. PubMed ID: 18698007
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
5. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.
Zeller B; Rajantie J; Hedlund-Treutiger I; Tedgård U; Wesenberg F; Jonsson OG; Henter JI;
Acta Paediatr; 2005 Feb; 94(2):178-84. PubMed ID: 15981751
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
Kjaersgaard M; Edslev PW; Rosthøj S
Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
[TBL] [Abstract][Full Text] [Related]
7. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
Medeiros D; Buchanan GR
J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
[TBL] [Abstract][Full Text] [Related]
8. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.
Neunert C; Noroozi N; Norman G; Buchanan GR; Goy J; Nazi I; Kelton JG; Arnold DM
J Thromb Haemost; 2015 Mar; 13(3):457-64. PubMed ID: 25495497
[TBL] [Abstract][Full Text] [Related]
9. Childhood ITP: can we venture below 20 000?
Abshire T
Blood; 2008 Nov; 112(10):3918-9. PubMed ID: 18988870
[No Abstract] [Full Text] [Related]
10. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
Treutiger I; Rajantie J; Zeller B; Henter JI; Elinder G; Rosthøj S;
Arch Dis Child; 2007 Aug; 92(8):704-7. PubMed ID: 17460024
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.
Adelborg K; Kristensen NR; Nørgaard M; Bahmanyar S; Ghanima W; Kilpatrick K; Frederiksen H; Ekstrand C; Sørensen HT; Fynbo Christiansen C
J Thromb Haemost; 2019 Jun; 17(6):912-924. PubMed ID: 30933417
[TBL] [Abstract][Full Text] [Related]
13. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
14. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
[TBL] [Abstract][Full Text] [Related]
15. Intracranial haemorrhage among Chinese children with immune thrombocytopenia in a Hong Kong regional hospital.
So MY; Li CH; Lee AC; Kwong NS
Hong Kong Med J; 2013 Apr; 19(2):129-34. PubMed ID: 23535672
[TBL] [Abstract][Full Text] [Related]
16. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura.
Chandra J; Ravi R; Singh V; Narayan S; Sharma S; Dutta AK
Hematology; 2006 Apr; 11(2):131-3. PubMed ID: 16753855
[TBL] [Abstract][Full Text] [Related]
17. Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
Pansy J; Minkov M; Dengg R; Quehenberger F; Lackner H; Nebl A; Sovinz P; Schwinger W; Urban C; Benesch M
Klin Padiatr; 2010 Nov; 222(6):374-7. PubMed ID: 21058224
[TBL] [Abstract][Full Text] [Related]
18. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
Glanz J; France E; Xu S; Hayes T; Hambidge S
Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
[TBL] [Abstract][Full Text] [Related]
19. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.
Zhou F; Xu Y; Zhang Z; Wu X; Jin R
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457
[TBL] [Abstract][Full Text] [Related]
20. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
